Results 51 to 60 of about 314,176 (271)

Respiratory disorders of post-COVID-19 syndrome

open access: yesTerapevticheskii arkhiv, 2023
Aim. Assess the functional state of trespiratory system and effectiveness of therapeutic tactics for broncho-obstructive syndrome (BOS) in patients in the post-COVID period. Materials and methods. A two-center cohort prospective study included 10 456 and 89 patients, respectively. A comprehensive assessment of the respiratory system included clinical,
Igor V. Leshchenko   +3 more
openaire   +3 more sources

Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report. [PDF]

open access: yes, 2021
It is not yet known, if critically ill COVID-19 patients are prone to fungal infections. We report a 69-year-old patient without typical risk factors for invasive pulmonary aspergillosis (IPA), who developed IPA two weeks after onset of symptoms.
Eller, Philipp   +5 more
core  

Post COVID-19 vaccine Guillain-Barré syndrome

open access: yesJournal of Nepal Health Research Council, 2022
Guillain-Barré syndrome is an acute generalized polyneuropathy which usually follows infection with a virus or bacteria, although rarely vaccination may be associated with it. We present a case of a 44-year-man who presented with progressive weakness of both lower limbs since 6?days, neurological examination findings were consistent with flaccid-type ...
Bikash, Khadka, Kishor, Khanal
openaire   +2 more sources

The co-administration of intranasal insulin and GLP-1RA as targeting drugs for prophylaxis and treatment of post COVID-19 smell and taste dysfunctions and brain fog

open access: yesAdvances in Biomedical and Health Sciences, 2023
The coronavirus disease (COVID-19) pandemic has resulted in high infection rates, significant morbidity, and postmortality among older adults, resulting in a global burden of COVID-19 survivors' long-term care.
Amr Ahmed, Aml M Barakat
doaj   +1 more source

Post‑COVID‑19 syndrome in children (Review)

open access: yesExperimental and Therapeutic Medicine, 2022
The persistence of symptoms for a long time after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is now familiar as post-COVID syndrome (PCS). To the best of our knowledge, the risk of long-term clinical outcomes in children after SARS-CoV-2 infection is still unclear.
Filippatos, Filippos   +2 more
openaire   +2 more sources

Efficacy of Therapeutic Exercise in Reversing Decreased Strength, Impaired Respiratory Function, Decreased Physical Fitness, and Decreased Quality of Life Caused by the Post-COVID-19 Syndrome

open access: yesViruses, 2022
In the current global scenario, many COVID-19 survivors present a severe deterioration in physical strength, respiratory function, and quality of life due to persistent symptoms and post-acute consequences of SARS-CoV-2 infection.
Diego Fernández-Lázaro   +4 more
doaj   +1 more source

Systemic impact of the post-Coronavirus disease syndrome in Brazil: Impacto sistêmico da síndrome da doença pós-Coronavírus no Brasil [PDF]

open access: yes, 2022
Background: Symptom persistence following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been recognized as the post-coronavirus disease (post-COVID-19) syndrome.
Botelho, Silvia Marçal   +5 more
core   +1 more source

Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19. [PDF]

open access: yes, 2020
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a novel beta-coronavirus that has recently emerged as the cause of the 2019 coronavirus pandemic (COVID-19).
Fitzgerald, Robert L   +5 more
core  

Steroid induced osteonecrosis: An analysis of steroid dosing risk. [PDF]

open access: yes, 2010
Osteonecrosis is a serious condition involving bone destruction that frequently requires surgical treatment to rebuild the joint. While there is an abundance of literature documenting corticosteroid related osteonecrosis, there is no consensus as to the ...
Chang, Christopher   +4 more
core   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy